Free Newsletters - Space - Defense - Environment - Energy
. Medical and Hospital News .

On-Demand Transfusions Could Yield Novel Therapeutics Delivery
by Staff Writers
Washington DC (SPX) Nov 20, 2013

Red blood cells viewed with a scanning electron micrograph using false color. Courtesy of Mustafa Mir, Sam Copeland and Gabriel Popescu via the National Science Foundation.

Red blood cells are the most transfused blood product in battlefield trauma care. Unfortunately, they are sometimes in limited supply in a battlefield environment. DARPA created its Blood Pharming program to potentially relieve this shortage by developing an automated culture and packaging system that would yield a fresh supply of transfusable red blood cells from readily available cell sources.

If the program is successful, it will eliminate the existing drawbacks of laboratory grown red blood cells, including cost, production efficiency and scalability, compared to those grown inside the human body. Pharmed blood could also offer additional benefits.

These potential benefits include eliminating the risk of infections from donors, on-demand availability, avoiding the detrimental effects of storing donated blood, and circumventing the issue of matching blood types between donor and recipient.

Before pharmed blood becomes practical for common use, the production costs must be significantly reduced. Under the Blood Pharming program, DARPA has decreased the cost of the chemical stock required to support blood growth for one unit of blood from more than $90,000 per unit to less than $5,000 per unit. DARPA believes that future reductions in the cost of chemical stock for unmodified red blood cells will eventually make pharmed blood practical for basic transfusions.

Recently, in addition to reducing production costs, DARPA performers have been investigating how pharmed red blood cells can potentially be modified to offer value-added benefits to the recipient beyond replenishing lost blood. Specifically, the Blood Pharming program is currently pursuing proofs of concept for customized red blood cells that offer such novel functionality.

A group of program performers led by Celgene Cellular Therapeutics is exploring ways to modify the surface or interior of red blood cells to serve as vessels that can hold a variety of medical payloads, including vaccines, anti-toxins, diagnostics, antibodies to neutralize pathogens, and novel therapeutics.

Unmodified blood could be taken from a donor and modified to deliver a particular medical payload. This modified blood could then be grown outside of the body and returned to the donor to provide a desired clinical response.

Since mature red blood cells do not contain a nucleus, their successful customization would represent a new class of cellular therapeutics that would provide DNA-free delivery of biologically based vaccines and therapeutics to treat disease and respond to trauma.

The modified blood cells could benefit a recipient for up to 120 days (the lifetime of a red blood cell) before naturally expiring from the recipient's system, extending the effective window of some therapies from hours to months.

Other modifications to red blood cells could result in universal donor cells that do not provoke immune reactions in recipients. In standard blood transfusions, the blood types of donor and recipient must be matched, which can be an issue when certain blood types are in low supply.

"We are pursuing several promising approaches to modification of red blood cells to carry payloads," said Dan Wattendorf, DARPA program manager for Blood Pharming.

"One line of research involves coupling proteins on the surface of a red blood cell with an inert chemical handle that can attach to virtually any payload. We've been initially successful, and even better, our team has shown that modifying these cells doesn't disrupt the ability to continue to grow them in a laboratory or to survive in an animal


Related Links
Blood Pharming at DARPA
Hospital and Medical News at

Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks DiggDigg RedditReddit GoogleGoogle

Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

New research finds high tungsten levels double stroke risk
Exeter, UK (SPX) Nov 14, 2013
High levels of tungsten in the body could double the risk of suffering a stroke, a new study published in the open access journal PLOS ONE has found. Using data from a large US health survey, the study has shown that high concentrations of tungsten - as measured in urine samples - is strongly linked with an increase in the occurrence of stroke, roughly equal to a doubling of the odds of experien ... read more

Grisly race to identify the Philippines' typhoon dead

China sends rescuers to Philippines after criticism over aid

Blow-up hospitals help Philippine typhoon effort

Australia-Indonesia relations dip further amid spying row

Russia to enforce GLONASS Over GPS

How pigeons may smell their way home

UK conservationists using location-based system ManagePlaces

A Better Way to Track Your Every Move

Ancient, modern DNA tell story of first humans in the Americas

DNA of early hominid found to include 'mystery' early genes

China one-child law change small but crucial: experts

Dogs likely originated in Europe more than 18,000 years ago

Land management as a key to countering butterfly declines

Evolution can select for evolvability

Nature's Glowing Slime: Scientists Peek into Hidden Sea Worm's Light

US destroys six-ton ivory stockpile

New malaria vaccines roadmap targets next generation products by 2030

Indonesian woman dies of bird flu: health ministry

Technology helps Nigeria's fight against polio

How zinc starves lethal bacteria to stop infection

Top China court calls for end to confession through torture

China reform pledges show Xi assuming Deng mantle: analysts

End to China labour camps cheered -- but what next?

China reform plan impresses, but analysts watch effects

Spain jails six Somalis for piracy

Pirates kidnap two American sailors off Nigeria

Seaman Guard owner to fight arrest of ship's crew in India

Somali pirates on trial for seizing French yacht

China unveils reforms to ease grip on economy

EU disciplines members over bloated budget deficits

China Communist Party vows to deepen reforms at key meeting

Walker's World: Are the Germans right?

The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement